Reverse Cardiac Remodeling: A Marker of Better Prognosis in Heart Failure
Arq Bras Cardiol. 2015 Jun;104(6):502-6.
doi: 10.5935/abc.20150025.
Epub 2015 Mar 27.
[Article in
English,
Portuguese]
Affiliation
- 1 Serviço de Cardiologia, Hospital Santa Marcelina, São Paulo, SP, Brazil.
Abstract
In heart failure syndrome, myocardial dysfunction causes an increase in neurohormonal activity, which is an adaptive and compensatory mechanism in response to the reduction in cardiac output. Neurohormonal activity is initially stimulated in an attempt to maintain compensation; however, when it remains increased, it contributes to the intensification of clinical manifestations and myocardial damage. Cardiac remodeling comprises changes in ventricular volume as well as the thickness and shape of the myocardial wall. With optimized treatment, such remodeling can be reversed, causing gradual improvement in cardiac function and consequently improved prognosis.
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Heart Failure / drug therapy*
-
Heart Failure / physiopathology
-
Humans
-
Prognosis
-
Stroke Volume / physiology
-
Time Factors
-
Ventricular Remodeling / drug effects*
-
Ventricular Remodeling / physiology
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors